We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Read MoreHide Full Article
Key Takeaways
Ingredion's Q2 adjusted EPS of $2.82 and net sales of $1.85 billion topped estimates.
Texture & Healthful Solutions volumes rose 7%, marking a ninth straight quarter of volume growth.
Argo production issues, weaker price mix and higher input costs pressured Ingredion's profitability.
Ingredion Incorporated (INGR - Free Report) delivered a resilient second-quarter 2026 performance despite production challenges at its Argo facility and macroeconomic pressure in Mexico. Continued momentum in Texture & Healthful Solutions, favorable currency movements and improving Protein Fortification results supported the quarter.
Adjusted earnings were $2.82 per share, which fell 1.7% year over year but topped the Zacks Consensus Estimate of $2.73.
Ingredion Incorporated Price, Consensus and EPS Surprise
Net sales increased 0.9% to $1,850 million and surpassed the consensus mark of $1,808 million. Texture & Healthful Solutions volumes rose 7%. Sales benefited from a $36 million favorable foreign exchange impact and a $20 million contribution from higher volume. These gains more than offset a $39 million unfavorable price-mix effect.
Ingredion's Profitability Faces Pressure
Reported gross profit declined 10.7% to $426 million, while the cost of sales increased to $1,424 million from $1,356 million. The pressure reflected manufacturing headwinds, unfavorable price mix and higher input costs, including elevated tapioca costs.
Adjusted operating income declined 5.5% to $258 million. The decrease primarily reflected Argo-related manufacturing issues and foreign exchange and macroeconomic headwinds in Mexico. Growth in Texture & Healthful Solutions and improved Protein Fortification performance partly offset these pressures.
INGR's Segment Performance Shows Mixed Trends
Texture & Healthful Solutions sales increased 4.7% to $627 million. Higher volume contributed $44 million and favorable foreign exchange added $5 million, partly offset by a $21 million unfavorable price-mix impact. Segment operating income rose 5.4% to $117 million, supported by volume growth but limited by higher tapioca costs and weaker price mix.
The segment recorded its ninth consecutive quarter of net sales volume growth. Demand remained broad-based across clean-label ingredients, texture solutions, sugar reduction, and protein and fiber fortification. Management noted that tapioca root prices had increased more than 40% since the start of 2026 because of weather-related supply constraints.
Food & Industrial Ingredients-LATAM sales increased 2.5% to $611 million as a $30 million currency benefit more than offset lower volume and unfavorable price mix. Segment operating income declined 7.1% to $118 million, primarily due to transactional currency pressure in Mexico and a more challenging demand environment. Excluding foreign exchange translation, operating income decreased 10%.
Food & Industrial Ingredients-U.S./Canada sales fell 6.7% to $488 million. Segment operating income declined 32.6% to $58 million because of lower Argo production, softer volumes and unfavorable price mix. Argo exited June at normal production rates across all major operating units after the company addressed grind, refinery and germ-processing issues.
All Other sales advanced 7.8% to $124 million, while operating income improved to $6 million from a loss of $1 million. The improvement reflected continued progress in Protein Fortification, where sales increased more than 40% on demand for higher-value isolates and specialty protein applications.
Ingredion's Cash Flow & Balance Sheet Status
Cash provided by operating activities came in at $123 million during the first six months of 2026. Capital expenditures totaled $210 million. Ingredion paid $105 million in dividends and repurchased $14 million of common stock during the first half. Cash and short-term investments were $952 million at quarter-end, while total debt stood at $1,783 million.
What to Expect From INGR Ahead?
For 2026, Ingredion reaffirmed its adjusted earnings guidance of $10.30-$10.90 per share. Net sales are expected to range from flat to low-single-digit growth, while adjusted operating income is projected to decline by a mid-single-digit percentage.
Texture & Healthful Solutions operating income is now forecasted to increase by a mid-to-high-single-digit percentage. U.S./Canada operating income is expected to decline 20%-25%, reflecting the Argo headwinds incurred during the first half.
Cash from operations is projected between $700 million and $800 million in 2026, with capital expenditures expected at $450-$490 million.
For the third quarter, net sales are anticipated to increase by a low-single-digit percentage, while adjusted operating income is expected to decline by a mid-single-digit percentage, reflecting the sale of Ingredion’s majority stake in Pakistan.
Shares of this Zacks Rank #4 (Sell) company have tumbled 17.2% over the past year, almost in line with the industry.
Better-Ranked Stocks to Consider
Darling Ingredients Inc. (DAR - Free Report) , a global developer and producer of sustainable natural ingredients derived from edible and inedible bio-nutrients, currently sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
The Zacks Consensus Estimate for Darling’s current fiscal year sales calls for 13.2% growth from the prior-year levels. The consensus estimate for current fiscal-year earnings per share (EPS) stands at $5.34, which implies substantial growth from the year-ago period. DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.
The Vita Coco Company, Inc. (COCO - Free Report) , a leading beverage company that develops, markets and distributes coconut water and other plant-based beverages, currently sports a Zacks Rank #1. COCO delivered a trailing four-quarter earnings surprise of 21.9%, on average.
The Zacks Consensus Estimate for The Vita Coco Company’s current fiscal-year sales and earnings calls for growth of 31.6% and 64.7%, respectively, from the year-ago figures.
US Foods Holding Corp. (USFD - Free Report) engages in the marketing, sale and distribution of fresh, frozen and dry food and non-food products to foodservice customers in the United States. USFD currently carries a Zacks Rank #2 (Buy). US Foods Holding delivered a trailing four-quarter earnings surprise of 1.4%, on average.
The Zacks Consensus Estimate for US Foods Holding’s current fiscal-year sales and earnings implies growth of 5.1% and 16.3%, respectively, from the year-ago figures.
View the Zacks #1 Rank List
Image: Bigstock
Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Key Takeaways
Ingredion Incorporated (INGR - Free Report) delivered a resilient second-quarter 2026 performance despite production challenges at its Argo facility and macroeconomic pressure in Mexico. Continued momentum in Texture & Healthful Solutions, favorable currency movements and improving Protein Fortification results supported the quarter.
Adjusted earnings were $2.82 per share, which fell 1.7% year over year but topped the Zacks Consensus Estimate of $2.73.
Ingredion Incorporated Price, Consensus and EPS Surprise
Ingredion Incorporated price-consensus-eps-surprise-chart | Ingredion Incorporated Quote
Net sales increased 0.9% to $1,850 million and surpassed the consensus mark of $1,808 million. Texture & Healthful Solutions volumes rose 7%. Sales benefited from a $36 million favorable foreign exchange impact and a $20 million contribution from higher volume. These gains more than offset a $39 million unfavorable price-mix effect.
Ingredion's Profitability Faces Pressure
Reported gross profit declined 10.7% to $426 million, while the cost of sales increased to $1,424 million from $1,356 million. The pressure reflected manufacturing headwinds, unfavorable price mix and higher input costs, including elevated tapioca costs.
Adjusted operating income declined 5.5% to $258 million. The decrease primarily reflected Argo-related manufacturing issues and foreign exchange and macroeconomic headwinds in Mexico. Growth in Texture & Healthful Solutions and improved Protein Fortification performance partly offset these pressures.
INGR's Segment Performance Shows Mixed Trends
Texture & Healthful Solutions sales increased 4.7% to $627 million. Higher volume contributed $44 million and favorable foreign exchange added $5 million, partly offset by a $21 million unfavorable price-mix impact. Segment operating income rose 5.4% to $117 million, supported by volume growth but limited by higher tapioca costs and weaker price mix.
The segment recorded its ninth consecutive quarter of net sales volume growth. Demand remained broad-based across clean-label ingredients, texture solutions, sugar reduction, and protein and fiber fortification. Management noted that tapioca root prices had increased more than 40% since the start of 2026 because of weather-related supply constraints.
Food & Industrial Ingredients-LATAM sales increased 2.5% to $611 million as a $30 million currency benefit more than offset lower volume and unfavorable price mix. Segment operating income declined 7.1% to $118 million, primarily due to transactional currency pressure in Mexico and a more challenging demand environment. Excluding foreign exchange translation, operating income decreased 10%.
Food & Industrial Ingredients-U.S./Canada sales fell 6.7% to $488 million. Segment operating income declined 32.6% to $58 million because of lower Argo production, softer volumes and unfavorable price mix. Argo exited June at normal production rates across all major operating units after the company addressed grind, refinery and germ-processing issues.
All Other sales advanced 7.8% to $124 million, while operating income improved to $6 million from a loss of $1 million. The improvement reflected continued progress in Protein Fortification, where sales increased more than 40% on demand for higher-value isolates and specialty protein applications.
Ingredion's Cash Flow & Balance Sheet Status
Cash provided by operating activities came in at $123 million during the first six months of 2026. Capital expenditures totaled $210 million. Ingredion paid $105 million in dividends and repurchased $14 million of common stock during the first half. Cash and short-term investments were $952 million at quarter-end, while total debt stood at $1,783 million.
What to Expect From INGR Ahead?
For 2026, Ingredion reaffirmed its adjusted earnings guidance of $10.30-$10.90 per share. Net sales are expected to range from flat to low-single-digit growth, while adjusted operating income is projected to decline by a mid-single-digit percentage.
Texture & Healthful Solutions operating income is now forecasted to increase by a mid-to-high-single-digit percentage. U.S./Canada operating income is expected to decline 20%-25%, reflecting the Argo headwinds incurred during the first half.
Cash from operations is projected between $700 million and $800 million in 2026, with capital expenditures expected at $450-$490 million.
For the third quarter, net sales are anticipated to increase by a low-single-digit percentage, while adjusted operating income is expected to decline by a mid-single-digit percentage, reflecting the sale of Ingredion’s majority stake in Pakistan.
Shares of this Zacks Rank #4 (Sell) company have tumbled 17.2% over the past year, almost in line with the industry.
Better-Ranked Stocks to Consider
Darling Ingredients Inc. (DAR - Free Report) , a global developer and producer of sustainable natural ingredients derived from edible and inedible bio-nutrients, currently sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here
The Zacks Consensus Estimate for Darling’s current fiscal year sales calls for 13.2% growth from the prior-year levels. The consensus estimate for current fiscal-year earnings per share (EPS) stands at $5.34, which implies substantial growth from the year-ago period. DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.
The Vita Coco Company, Inc. (COCO - Free Report) , a leading beverage company that develops, markets and distributes coconut water and other plant-based beverages, currently sports a Zacks Rank #1. COCO delivered a trailing four-quarter earnings surprise of 21.9%, on average.
The Zacks Consensus Estimate for The Vita Coco Company’s current fiscal-year sales and earnings calls for growth of 31.6% and 64.7%, respectively, from the year-ago figures.
US Foods Holding Corp. (USFD - Free Report) engages in the marketing, sale and distribution of fresh, frozen and dry food and non-food products to foodservice customers in the United States. USFD currently carries a Zacks Rank #2 (Buy). US Foods Holding delivered a trailing four-quarter earnings surprise of 1.4%, on average.
The Zacks Consensus Estimate for US Foods Holding’s current fiscal-year sales and earnings implies growth of 5.1% and 16.3%, respectively, from the year-ago figures.